These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24858397)

  • 41. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
    Yang Y; Li N; Nie Y; Sheng M; Yue D; Wang G; Tang JZ; Gu Z
    J Biomed Nanotechnol; 2015 Sep; 11(9):1628-39. PubMed ID: 26485931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
    Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
    Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surface-modified cationic liposomes with a matrix metalloproteinase-degradable polyethylene glycol derivative improved doxorubicin delivery in murine colon cancer.
    Askarizadeh A; Mashreghi M; Mirhadi E; Mehrabian A; Heravi Shargh V; Badiee A; Alavizadeh SH; Arabi L; Kamali H; Jaafari MR
    J Liposome Res; 2024 Jun; 34(2):221-238. PubMed ID: 37647288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Folate-functionalized assembly of low density lipoprotein/sodium carboxymethyl cellulose nanoparticles for targeted delivery.
    Liang H; He L; Zhou B; Li B; Li J
    Colloids Surf B Biointerfaces; 2017 Aug; 156():19-28. PubMed ID: 28499201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting.
    Ran R; Wang H; Liu Y; Hui Y; Sun Q; Seth A; Wibowo D; Chen D; Zhao CX
    Eur J Pharm Biopharm; 2018 Sep; 130():1-10. PubMed ID: 29908938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human Breast Cancer.
    Liao TT; Han JF; Zhang FY; Na R; Ye WL
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
    Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S
    Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
    Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
    Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
    Kang MJ; Park SH; Kang MH; Park MJ; Choi YW
    Int J Nanomedicine; 2013; 8():1155-65. PubMed ID: 23515421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.
    Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q
    J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
    Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
    Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy.
    Chen W; Li J; Xing Y; Wang X; Zhang H; Xia M; Wang D
    Pharm Res; 2020 Jul; 37(7):134. PubMed ID: 32642819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
    Wang RH; Cao HM; Tian ZJ; Jin B; Wang Q; Ma H; Wu J
    Oncol Rep; 2015 Feb; 33(2):783-91. PubMed ID: 25482610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.
    Ding N; Lu Y; Lee RJ; Yang C; Huang L; Liu J; Xiang G
    Int J Nanomedicine; 2011; 6():2513-20. PubMed ID: 22072885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.
    Shi NQ; Li Y; Zhang Y; Li ZQ; Qi XR
    Int J Nanomedicine; 2018; 13():5537-5559. PubMed ID: 30271146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.